<DOC>
	<DOCNO>NCT02638220</DOCNO>
	<brief_summary>This observational , multicenter study determine prevalence Cerebrotendinous Xanthomatosis ( CTX ) patient population diagnose early-onset idiopathic bilateral cataract . Patients potentially eligible study participation identify chart review patient see study site prior site 's initiation , enter care site site participate trial .</brief_summary>
	<brief_title>Cerebrotendinous Xanthomatosis ( CTX ) Prevalence Study</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Xanthomatosis</mesh_term>
	<mesh_term>Xanthomatosis , Cerebrotendinous</mesh_term>
	<criteria>1 . The patient diagnosis idiopathic bilateral cataract . 2 . Between age 2 21 year time diagnosis 1 . The patient diagnosis cataract know etiology CTX . 2 . The patient diagnosis CTX . 3 . The patient cataract cause cataractogenic treatment . 4 . The patient take currently take cholic acid chenodeoxycholic acid . 5 . The patient participate interventional clinical trial past 30 day . 6 . The patient and/or parent/legal guardian , opinion Investigator , unable adhere requirement study .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Cerebrotendinous Xanthomatosis</keyword>
	<keyword>CTX Prevalence Study</keyword>
	<keyword>CTX</keyword>
	<keyword>Idiopathic Bilateral Cataracts</keyword>
	<keyword>Cataracts</keyword>
	<keyword>Bilateral Cataracts</keyword>
	<keyword>Early-Onset Idiopathic Bilateral Cataracts</keyword>
	<keyword>Observational Study</keyword>
	<keyword>Ophthalmology</keyword>
</DOC>